Loading company…
PharmaSEAL is a Nottingham, UK clinical trial management company offering the Engility CTMS eTMF cloud platform.
Founded in 2016 and based in Nottingham, UK, PharmaSEAL provides clinical trial management through Engility, a cloud-based adaptive platform that combines trial management with electronic trial master file functions. It serves biopharma, medical device, contract research, academic, nutraceutical and cosmetics companies on a subscription basis. The company raised GBP 664 thousand on December 15, 2020, from Seedrs and individual investors, at a valuation of GBP 1.78 million. CEO and founder Daljit Cheema leads the company.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in